Brief: LSL Pharma Group Announces Listing Of Convertible Redeemable Debentures On The TSXV
22/05/2024 12:02
May 22 (Reuters) - LSL Pharma Group Inc LSL.V :
* LSL PHARMA GROUP ANNOUNCES LISTING OF CONVERTIBLE
REDEEMABLE
DEBENTURES ON THE TSXV
* LSL PHARMA DEBENTURES TO MATURE IN 2028
Source text for Eikon: ID:nGNXp93Dh
Further company coverage: LSL.V
((Reuters.Brief@thomsonreuters.com;))
Recent news on LSL Pharma
See all newsBrief: LSL Pharma Group Announces CFO Transition
Canada's LSL Pharma Q2 revenue surges on acquisition boost, eye-drop launches
Brief: Lsl Pharma Group Reports Record Revenues And Second Quarter 2026 Results
Brief: LSL Pharma Group Successfully Obtained U.S. FDA Certification For The Manufacturing Of Ophthalmic Ointments For Commercialization In The United States
Brief: LSL Pharma Group Announces Closing Of The Acquisition Of Juno Otc And Final $2M Closing Of Upsized $12M Offering